Philippines vs Réunion: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Philippines
0.8%
in 2024
Réunion
0.8%
in 2024
Philippines rank
37th
Réunion rank
37th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Philippines
- Réunion
How they compare
Philippines currently reports 0.8% against 0.8% in Réunion, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Réunion ahead.
Philippines ranks 37th and Réunion ranks 37th of 215 countries.
Across the 2 decades both report, Philippines averaged higher in 1 and Réunion in 1.
Head to head by decade
| Decade | Philippines | Réunion | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.2% | 0.3% | Réunion |
| 2020s | 0.9% | 0.8% | 0.0% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Philippines or Réunion?
- Philippines, at 0.8% against 0.8% in Réunion as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Philippines and Réunion?
- 0.0%, with Philippines ahead.
- How many years of comparable data are there for Philippines and Réunion?
- 10 years are reported by both, from 2015 to 2024.
- How do Philippines and Réunion rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Philippines ranks 37th and Réunion ranks 37th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.